Original Research
Published on 05 Feb 2025
Ocrelizumab-induced colitis—critical review and case series from a Romanian cohort of MS patients
in Multiple Sclerosis and Neuroimmunology
- 2,065 views
Original Research
Published on 05 Feb 2025
in Multiple Sclerosis and Neuroimmunology
Editorial
Published on 04 Feb 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 04 Feb 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 30 Jan 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 27 Jan 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 13 Jan 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 06 Jan 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 03 Jan 2025
in Multiple Sclerosis and Neuroimmunology
Perspective
Published on 31 Dec 2024
in Multiple Sclerosis and Neuroimmunology
Systematic Review
Published on 17 Dec 2024
in Multiple Sclerosis and Neuroimmunology
Review
Published on 17 Dec 2024
in Multiple Sclerosis and Neuroimmunology
Perspective
Published on 13 Dec 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 13 Dec 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 11 Dec 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 11 Dec 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 09 Dec 2024
in Multiple Sclerosis and Neuroimmunology